a diabetes treatment soon to be recommended to treat obesity?

If the Security Agency warns of the dangers of misuse of Ozempic, researchers are considering using it in the treatment of obesity, “but under another name: Wegovy, and with stronger dosages”reveals Damien Mascret. “The drug manufacturers, seeing the weight loss effect in treated diabetics, immediately launched studies in obese people who were not diabetics”adds the journalist. “Weight loss was significant, down to minus 17% of body weight after 16 months of treatment.” The problem is that the weight can be quickly regained as soon as the treatment is stopped.

General practitioners not authorized to prescribe this treatment?

Steps should be taken to prevent abuse. “We will probably not be able to go to our general practitioner to be prescribed the drug. The Haute Autorité de Santé wants to restrict the prescription only to doctors specializing in obesity, as well as to doctors who work in specialized obesity centers or university hospitals.let Damien Mascret know before concluding. “We’ll see what happens, because the price is not fixed yet, so the WEGOVY is not yet available.”